<DOC>
	<DOCNO>NCT01412710</DOCNO>
	<brief_summary>The purpose present pilot study determine effect vitamin D supplementation ( 4000 IU 6000 IU daily 6 month ) reduce heart disease risk improve blood glucose control type 2 Diabetes subject . The investigator work Hispanics African Americans live Miami , Florida .</brief_summary>
	<brief_title>The Effect Vitamin D Supplementation Cardiovascular Risk Factors Among Hispanics African Americans With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>Insufficient vitamin D level find subject type 2 diabetes ( T2D ) . Similarly , negative association serum vitamin D level insulin resistance report large sample representative adult US population subject risk T2D . In addition , strong association hypovitaminosis D hypertriglyceridemia demonstrate study do US adult population . Literature indicate subject T2D insulin resistance ( IR ) likely develop arteriosclerosis complication related condition , myocardial infarction stroke . These finding increase interest effect vitamin D metabolic abnormality group term `` cardiovascular disease ( CVD ) risk factor '' , include hypertension , dyslipidemia , obesity , glucose intolerance , inflammation T2D risk factor CVD . Therefore , purpose present pilot study determine effect supplemental vitamin D intake ( 4000 IU 6000 IU Cholecalciferol daily 6 month ) CVD risk marker glycemic control ; primarily lipid panel , insulin resistance , glycosylated hemoglobin ( A1C ) , sample Hispanics African-Americans T2D vitamin D insufficiency . If repletion vitamin D level improve insulin resistance , glycemic control , inflammation , hypertension , dyslipidaemia kidney function , may prevent development CVD event decrease T2D complication .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Type 2 diabetes African American Hispanic able ambulate age 30 70 year Taking Supplemental Vitamin D Pregnant Lactating woman Receiving insulin therapy Not participate drug trial HIV/ hepatitis/ cancer/ liver disease/ heart failure/ recent surgery/ mental illness/ epilepsy/ GI malabsorption disorder</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Cholecalciferol</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Cardiovascular disease risk</keyword>
	<keyword>Minorities</keyword>
</DOC>